Abstract
Magnetic Resonance Spectroscopy (MRS) is a non-invasive technique that quantitatively measures the metabolic composition of tissues in vivo using conventional magnetic resonance (MR) scanners. This technology is of special interest for clinical applications in psychiatry due to its non-invasive nature. In recent years, studies have demonstrated its diagnostic capability in psychiatric conditions such as schizophrenia, bipolar disorder, depression, as well as in neurodegenerative disorders and neuro-oncology among others. The most relevant brain chemicals that can be quantified include: N-acetylaspartate (NAA), a neuronal marker; creatine (Cr), involved in energy metabolism; choline (Cho), a key component of myelin; glutamate (Glu), an excitatory neurotransmitter; γ-aminobutyric acid (GABA), an inhibitory neurotransmitter, and glutathione (GSH), an anti-oxidant involved in neuroinflammation. In this chapter, the biological roles of the primary brain metabolites will be discussed. Moreover, the general principles of MRS and the specialized pulse sequences that enable the detection of each of these metabolites will be described. Furthermore, a comprehensive introduction of the most common techniques and examination protocols used in research and clinical applications will be presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 13C:
-
Carbon 13
- 2D COSY:
-
Two-Dimensional COrrelated SpectroscopY
- 2D JPRESS:
-
Two-Dimensional J-resolved Point RESolved Spectroscopy
- Cho:
-
Choline
- Cr:
-
Creatine
- CRLB:
-
Cramer–Rao lower bounds
- CSI:
-
Chemical shift imaging
- FT:
-
Fourier transform
- FID:
-
Free induction decay
- fMRI:
-
functional magnetic resonance imaging
- GABA:
-
gamma-Aminobutyric acid
- Gln:
-
Glutamine
- Glu:
-
Glutamate
- Glx:
-
Both glutamate and glutamine
- GPC:
-
Glycerophosphocholine
- GSH:
-
Glutathione
- JPRESS:
-
J-resolved Point RESolved Spectroscopy
- MCI:
-
Mild cognitive impairment
- MEGA PRESS:
-
MEscher-GArwood Point RESolved Spectroscopy
- mI:
-
myo-Inositol
- MRI:
-
Magnetic resonance imaging
- MRS:
-
Magnetic resonance spectroscopy
- NAA:
-
N-Acetylaspartate
- NAAG:
-
N-Acetylaspartylglutamate
- NMDA:
-
N-Methyl-D-aspartic acid
- NMR:
-
Nuclear magnetic resonance
- PCP:
-
Phencyclidine
- PC:
-
Phosphorylcholine
- PCr:
-
Phosphocreatine
- PET:
-
Positron emission tomography
- PRESS:
-
Point RESolved Spectroscopy
- RF:
-
Radiofrequency
- ROI:
-
Region of interest
- ROS:
-
Reactive oxygen species
- STEAM:
-
STimulated Echo Acquisition Mode
- SVS:
-
Single voxel spectroscopy
- TCA:
-
Tricarboxylic acid cycle
- TE:
-
Echo time
- TI:
-
Inversion time
- TR:
-
Relaxation time
References
Agostinho P, Cunha RA, Oliveira C, et al. Curr Pharm Des. 2010;16(25):2766–78.
Andrew ER. N.m.r. imaging of intact biological systems. Philos Trans R Soc Lond B Biol Sci. 1980;289(1037):471–81.
Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen AG. Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J Magn Reson [Internet]. 2010;203(2):283–93. https://doi.org/10.1016/j.jmr.2010.01.010.
Aue WP, Bartholdi E, Ernst RR. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J Chem Phys [Internet]. 1976;64(5):2229–46. https://doi.org/10.1063/1.432450.
Barker PB. N-acetyl aspartate--a neuronal marker? Ann Neurol. 2001;49(4):423–4.
Barkhuijsen H, de Beer R, van Ormondt D. Improved algorithm for noniterative time-domain model fitting to exponentially damped magnetic resonance signals. J Magn Reson [Internet]. 1987;73(3):553–7. http://linkinghub.elsevier.com/retrieve/pii/0022236487900230.
Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci. 2002;3(9):728–39.
Bhattacharyya PK, Lowe MJ, Phillips MD. Spectral quality control in motion-corrupted single-voxel J-difference editing scans: an interleaved navigator approach. Magn Reson Med. 2007;58(4):808–12.
Bloch F. Nuclear induction. Phys Rev [Internet]. 1946;70(7–8):460–74. https://link.aps.org/doi/10.1103/PhysRev.70.460.
Bloch F, Hansen WW, Packard M. The nuclear induction experiment. Phys Rev [Internet]. 1946;70(7–8):474–85. https://link.aps.org/doi/10.1103/PhysRev.70.474.
Bluml S, Zuckerman E, Tan J, Ross BD. Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem. 1998;71(4):1564–76.
Blüml S, Tan J, Harris K, Adatia N, Karme A, Sproull T, et al. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo. J Comput Assist Tomogr. 1999;23(2):272–5.
Bolan PJ, DelaBarre L, Baker EH, Merkle H, Everson LI, Yee D, et al. Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med. 2002;48:215–22.
Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci [Internet]. 1987;508:333–48. https://doi.org/10.1111/j.1749-6632.1987.tb32915.x.
Caverzasi E, Pichiecchio A, Poloni GU, Calligaro A, Pasin M, Palesi F, et al. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol. 2012;27(1):13–22.
Cocuzzo D, Lin A, Ramadan S, Mountford C, Keshava N. Algorithms for characterizing brain metabolites in two-dimensional in vivo MR correlation spectroscopy. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:4929–34.
Coello E, Noeske R, Burns BL, Gordon JW, Jakary A, Menze B, et al. High-resolution echo-planar spectroscopic imaging at ultra-high field. NMR Biomed [Internet]. 2018:e3950. https://doi.org/10.1002/nbm.3950.
Cunningham CH, Vigneron DB, Chen AP, Xu D, Nelson SJ, Hurd RE, et al. Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med. 2005;54(5):1286–9.
Dreher W, Leibfritz D. On the use of 2-Dimensional-J NMR measurements for in-vivo proton MRS- measurement of homonuclear decoupled spectra without the need for short echo times. Magn Reson Med. 1995;34(3):331–7.
Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain. Eur J Biochem. 2000;267(16):4912–6.
Du F, Cooper AJ, Thida T, Shinn AK, Cohen BM, Öngür D. Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques. Biol Psychiatry [Internet]. 2013;74(6):451–7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720707/.
Du F, Cooper AJ, Thida T, Sehovic S, Lukas SE, Cohen BM, et al. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31 P magnetization transfer spectroscopy. JAMA Psychiatry [Internet]. 2014;71(1):19. +.
Edden RAE, Barker PB. Spatial effects in the detection of γ-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med. 2007;58(6):1276–82.
Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 1989;9(1):79–93.
Frey BN, Stanley JA, Nery FG, Monkul ES, Nicoletti MA, Chen H-H, et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord. 2007;9(Suppl 1):119–27.
Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed [Internet]. 2000;13:129–53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10861994.
de Graaf RA. In vivo NMR spectroscopy - principles and techniques. 2nd ed. Hoboken: Wiley; 2007.
Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shulman GI, et al. Localized 13C NMR spectroscopy in the human brain of amino acid labeling from d-[1-13C]glucose. J Neurochem. 1994;63(4):1377–85.
Haase A, Frahm J, Matthaei D, Hänicke W, Bomsdorf H, Kunz D, et al. MR imaging using stimulated echoes (STEAM). Radiology. 1986;160(3):787–90.
Harris K, Lin A, Bhattacharya P, Tran T, Wong W, Ross B. Regulation of NAA-synthesis in the human brain in vivo: Canavan’s disease, Alzheimer’s disease and schizophrenia. In: N-Acetylaspartate [Internet]. New York: Springer; 2006. p. 263–73. http://link.springer.com/10.1007/0-387-30172-0_18.
Hertz L, Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004;27(12):735–43.
Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med. 2004;51(3):435–40.
Jeener J, Meier BH, Bachmann P, Ernst RR. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys. 1979;71(11):4546.
Jensen JE, Frederick BD, Wang L, Brown J, Renshaw PF. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magn Reson Med. 2005;54(4):783–8.
Kaiser LG, Young K, Matson GB. Elimination of spatial interference in PRESS-localized editing spectroscopy. Magn Reson Med. 2007;58(4):813–8.
Kantarci K. 1H magnetic resonance spectroscopy in dementia. Br J Radiol. 2007;80 Spec No:S146–52.
Kantarci K. Proton MRS in mild cognitive impairment. J Magn Reson Imaging. 2013;37(4):770–7.
Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord. 1994;31(2):125–33.
Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res. 2000;100(3):169–78.
Kegeles LS, Humaran TJ, Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry. 1998;44(6):382–98.
Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med [Internet]. 1990;14(1):26–30. http://www.ncbi.nlm.nih.gov/pubmed/2161984.
Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, et al. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res. 2012;203(2–3):111–25.
Lin A, Ross BD, Harris K, Wong W. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx. 2005;2(2):197–214.
Lymer K, Haga K, Marshall I, Sailasuta N, Wardlaw J. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy. Magn Reson Imaging. 2007;25(5):634–40.
Maddock RJ, Buonocore MH. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci. 2012;11:199–251.
Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ. Simultaneous determination of the rates of the TCA cycle, glucose utilization, μ-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab. 1995;15(1):12–25.
Matsuzawa D, Hashimoto K. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid Redox Signal. 2011;15(7):2057–65.
Mlynárik V, Gambarota G, Frenkel H, Gruetter R. Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med [Internet]. 2006;56(5):965–70. https://doi.org/10.1002/mrm.21043.
Moffett JR, Namboodiri MA, Neale JH. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J Histochem Cytochem. 1993;41(4):559–70.
Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89–131.
Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, et al. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson’s disease. Clin Neurosci Res. 2006;6(5):261–81.
Mullins PG, McGonigle DJ, O’Gorman RL, Puts NAJ, Vidyasagar R, Evans CJ, et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage. 2014;86:43–52.
Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med [Internet]. 2001;31(4):269–86. http://www.sciencedirect.com/science/article/pii/S0010482501000063.
Ongür D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res. 2009;172(1):44–8.
Öz G, Terpstra M, Tkáč I, Aia P, Lowary J, Tuite PJ, et al. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006;55(2):296–301.
Öz G, Alger JR, Barker PB, Bartha R, Bizzi A, Boesch C, et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology [Internet]. 2014;270(3):658–79. http://pubs.rsna.org/doi/10.1148/radiol.13130531.
Pellerin L, Magistretti P. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91:10625–9.
Posse S, DeCarli C, Le Bihan D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology [Internet]. 1994;192(3):733–8. http://pubs.rsna.org/doi/abs/10.1148/radiology.192.3.8058941.
Posse S, Tedeschi G, Risinger R, Ogg R, Le Bihan D. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med. 1995;33(1):34–40.
Posse S, Otazo R, Dager SR, Alger J. MR spectroscopic imaging: principles and recent advances. J Magn Reson Imaging. 2013;37(6):1301–25.
Potwarka JJ, Drost DJ, Williamson PC, Carr T, Canaran G, Rylett WJ, et al. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biol Psychiatry [Internet]. 1999;45(6):687–93. http://linkinghub.elsevier.com/retrieve/pii/S000632239800136X
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med [Internet]. 1993;30(6):672–9. http://www.ncbi.nlm.nih.gov/pubmed/8139448.
Purcell EM, Torrey HC, Pound RV. Resonance absorption by nuclear magnetic moments in a solid. Phys Rev [Internet]. 1946;69(1–2):37–8. https://link.aps.org/doi/10.1103/PhysRev.69.37.
Ramadan S, Andronesi OC, Stanwell P, Lin AP, Sorensen AG, Mountford CE. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. Radiology. 2011;259(2):540–9.
Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009;34(6):1021–9.
Ross BD. Real or imaginary? Human metabolism through nuclear magnetism. IUBMB Life. 2000;50(3):177–87.
Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265(2):54–84.
Rothman DL, Behar KL, Hetherington HP, Shulman RG. Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci [Internet]. 1984;81(20):6330–4. http://www.pnas.org/cgi/doi/10.1073/pnas.81.20.6330.
Rowland BC, Liao H, Adan F, Mariano L, Irvine J, Lin AP. Correcting for frequency drift in clinical brain MR spectroscopy. J Neuroimaging [Internet]. 2017;27(1):23–8. https://doi.org/10.1111/jon.12388.
Scheenen TWJ, Klomp DWJ, Wijnen JP, Heerschap A. Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med. 2008a;59(1):1–6.
Scheenen TW, Heerschap A, Klomp DW. Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. MAGMA. 2008b;21(1–2):95–101.
Schousboe A. Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem Res. 2003;28(2):347–52.
Schousboe A, Waagepetersen H. Role of astrocytes in glutamate homeostasis: implications for excitotoxicity. Neurotox Res. 2005;8(3):221–5.
Schulte RF, Boesiger P. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed. 2006;19(2):255–63.
Schulte RF, Lange T, Beck J, Meier D, Boesiger P. Improved two-dimensional J-resolved spectroscopy. NMR Biomed. 2006;19(2):264–70.
Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A. 1998;95(1):316–21.
Terpstra M, Ugurbil K, Gruetter R. Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn Reson Med. 2002;47(5):1009–12.
Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, et al. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med. 2001;46(1):58–67.
Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem. 1992;59(1):55–61.
Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35–43.
Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging. 2007;25(7):1032–8.
Wilson M, Reynolds G, Kauppinen RA, Arvanitis TN, Peet AC. A constrained least-squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magn Reson Med [Internet]. 2011;65(1):1–12. https://onlinelibrary.wiley.com/doi/abs/10.1002/mrm.22579.
Zierhut ML, Ozturk-Isik E, Chen AP, Park I, Vigneron DB, Nelson SJ. 1 H spectroscopic imaging of human brain at 3 Tesla: Comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques. J Magn Reson Imaging [Internet]. 2009;30(3):473–80. https://doi.org/10.1002/jmri.21834.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Coello, E., Starr, T.C., Lin, A.P. (2020). Magnetic Resonance Spectroscopy Methods. In: Kubicki, M., Shenton, M. (eds) Neuroimaging in Schizophrenia . Springer, Cham. https://doi.org/10.1007/978-3-030-35206-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-35206-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35205-9
Online ISBN: 978-3-030-35206-6
eBook Packages: MedicineMedicine (R0)